Web sitemizi kullanabilmek için javascript özelliğini etkinleştirmeniz gerekmektedir.

MPL Care (MPARK) 3Q25 Financial Results

Bimas Menkul Yatırım Investment

We evaluate MLP Healthcare’s 3Q25 financial results as neutral. We maintain our 12-month target price of TL 450 per share and our “HOLD” recommendation.

Detailed PDF   -   268 KB
Your transaction is being processed. Please wait.